Molecules 2000, 5(2), 99-113; doi:10.3390/50200099
Article

Novel Coumarin Derivatives with Expected Biological Activity

Received: 13 August 1999; Accepted: 20 October 1999 / Published: 16 February 2000
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: A number of novel 3-bromo-4-methyl-7-methoxy-8-amino substituted coumarins and 2-substituted 7-bromo-6-methyl-8H-pyrano-benzimidazoles, benzoxazoles and/or benzoxazine-8-ones were synthesized for the purpose of pharmacological evaluation. Some representative compounds showed antitumor activity in vitro on Ehrlich ascites carcinoma in the preliminary testing.
Keywords: Substituted coumarins; nitro reduction; benzylidinyl amino coumarins
PDF Full-text Download PDF Full-Text [101 KB, uploaded 18 June 2014 19:25 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Nofal, Z.M.; El-Zahar, M.I.; Abd El-Karim, S.S. Novel Coumarin Derivatives with Expected Biological Activity. Molecules 2000, 5, 99-113.

AMA Style

Nofal ZM, El-Zahar MI, Abd El-Karim SS. Novel Coumarin Derivatives with Expected Biological Activity. Molecules. 2000; 5(2):99-113.

Chicago/Turabian Style

Nofal, Z. M.; El-Zahar, M. I.; Abd El-Karim, S. S. 2000. "Novel Coumarin Derivatives with Expected Biological Activity." Molecules 5, no. 2: 99-113.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert